A federal judge certified several classes of direct and end-payer purchasers for test trials in drug price-fixing litigation against makers of two generic drugs, clomipramine and clobetasol.

Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

the general consensus was that the drug class was an R&D dead end. Merck's exit came after other companies including Pfizer, Eli Lilly and Roche all scrapped CETP development programmes following ...

The diabetes and weight loss drug market is heating up in 2025 ... fundamental and strategic value for their potentially best-in-class portfolio of obesity and metabolic disease programs." ...

Background and Aims: Since the publication of the Asia-Pacific GERD consensus in2004, more data concerning the epidemiology and management of gastroesophageal refluxdisease (GERD) have emerged. An ...

Phentermine is an appetite suppressant, prescribed for exogenous obesity.

A drug shortage is when a drug manufacturer isn't able to supply enough of a drug to meet all of its Canadian orders on time. The words drug, medication and medicine are often used interchangeably.